SCNTP™ · the science

Somatic Cell Nuclear Transfer — the Science Behind SCNTP™

The short answer. Somatic cell nuclear transfer (SCNT) takes the nucleus of an ordinary body cell — which carries the patient's complete genome — and places it into an egg cell whose own nucleus has been removed. The egg's cytoplasm resets that nucleus to pluripotency: the cell regains the ability to become any cell type of the body. The result is a patient-matched pluripotent stem-cell line. The reset is real and published; doing it efficiently and affordably is the open problem SCNTP™ works on.

How nuclear transfer works

The procedure has four moves. A donor body cell contributes its nucleus. An egg cell (oocyte) has its own nucleus removed. The donor nucleus is transferred into the enucleated egg, and the egg is activated — by an electrical or chemical pulse — as if it had been fertilised. If the reset succeeds, the embryo develops to the blastocyst stage, from which a pluripotent stem-cell line can be derived.[PubMed]

Somatic cell nuclear transfer in one viewA four-step schematic: a donor body cell contributes its nucleus; an egg cell's own nucleus is removed; the nucleus is transferred and the egg activated; the resulting cells grow into a patient-matched pluripotent stem-cell line.1 · Donor body cellits nucleus carries thepatient's whole genome2 · Enucleated eggthe egg's own nucleusis removed3 · Transfer + activationthe egg's cytoplasm resetsthe donor nucleus4 · Pluripotent linepatient-matched stem cellsgrown in culture
Somatic cell nuclear transfer, schematic. Scientific illustration — not experimental imagery.

The principle is sixty years old. In 1962 John Gurdon showed that a nucleus taken from a feeding tadpole's intestinal cell could support the development of a new tadpole — proof that a differentiated cell's genome still holds the whole programme.[PubMed] In 1997 the Roslin team extended the result to an adult mammal: Dolly the sheep was born from an udder-cell nucleus.[PubMed] Both results are the foundation the field still builds on, and both earned the 2012 Nobel Prize's first half.[Nobel Prize]

What the published evidence shows

Established — the reset itself
Somatic nuclei can be returned to pluripotency. Demonstrated across species from frog[PubMed] and sheep[PubMed] to rhesus macaque embryonic stem-cell lines[PubMed] and, in 2018, cloned macaque monkeys born alive.[PubMed] Established
Human cells — in vitro
Human embryonic stem-cell lines were derived by SCNT in 2013[PubMed], then from adult cells in 2014[PubMed] — including a line reprogrammed from the cells of a type 1 diabetic adult.[PubMed] Patient-matched pluripotent cells by nuclear transfer are therefore a published fact at the bench. Human · in vitro
Animal health of clones
An early worry — that clones inherit shortened telomeres and age early[PubMed] — was answered directly: cloned sheep followed into old age stayed healthy, with no telomere-driven decline.[PubMed] Animal
Efficiency — the binding constraint
Cloning efficiencies remain low and definition-dependent; even the successful primate work needed large numbers of oocytes and embryos per live birth,[PubMed] and primate nuclear transfer failed for years on spindle-removal mechanics before it succeeded.[PubMed] Reviews of the field's improvement strategies treat efficiency as the unresolved variable.[PubMed] Open problem

SCNT and iPSC: two roads to the same reset

In 2006 Takahashi and Yamanaka showed that four defined factors reprogram a mouse body cell to pluripotency with no egg at all[PubMed] — extended to human cells a year later by two groups independently.[PubMed][PubMed] Induced pluripotent stem cells (iPSCs) won the 2012 Nobel Prize's second half and, being egg-free and comparatively cheap, became the field's workhorse — including the first autologous iPSC-derived retinal transplant reported in 2017.[PubMed]

Why work on SCNT at all, then? Because the two resets are not identical. iPSCs retain an epigenetic memory of the cell they came from, which can bias what they become[PubMed][PubMed], while the egg's cytoplasm performs the most complete reprogramming known in biology. SCNT is the reference standard the factor-based methods are measured against — and the route whose cost curve has the most room to move. Programme rationale

The hard limits, stated plainly

Oocytes are scarce. Every SCNT attempt consumes a human or animal egg; no factor-based shortcut exists for the cytoplasmic reset itself. This is the largest single cost driver.

Efficiency is low. Cloning success stays in the low single digits of attempts in much of the published record, and improvement is an active research front rather than a solved problem.[PubMed]

The field has a fraud scar. The 2004–2005 claims of patient-specific human SCNT stem-cell lines by Hwang and colleagues were retracted in January 2006 after the data were shown to be fabricated.[PubMed] The episode is the reason this page cites primary sources for every claim and labels what is established and what is not.

Governance is settled at the top level. The World Health Assembly resolutions of 1997 and 1998 draw the line the field works within: reproductive cloning of human beings is rejected; research toward therapies proceeds under national oversight.[WHO IRIS][WHO IRIS]

No therapy is approved. As of September 2026, no SCNT-derived cell therapy has regulatory approval anywhere. The nearest clinical evidence in the pluripotent field is iPSC-based.[PubMed]

Where SCNTP™ fits

SCNTP™ — the Somatic Cell Nuclear Transfer Protocol — is Panacea Bio Chem's programme on exactly the constraint list above: a protocol designed from the start for cost, paired with the company's peptide, formulation and preservation technology. The programme is a direction of work, presented as such; its parameters are proprietary and not publicly disclosed.

The full scientific case is the homepage essay, the historical record is the legacy page, and the people behind the programme are on the about page.

References

  1. Gurdon JB. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol. 1962 Dec;10:622-40. PMID 13951335Established — animal
  2. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997;385(6619):810-3. PMID 9039911 · DOI 10.1038/385810a0Established — animal
  3. Shiels PG, Kind AJ, Campbell KH, et al. Analysis of telomere lengths in cloned sheep. Nature. 1999;399(6734):316-7. PMID 10360570Animal evidence
  4. Sinclair KD, Corr SA, Gutierrez CG, et al. Healthy ageing of cloned sheep. Nat Commun. 2016;7:12359. PMID 27459299Animal evidence
  5. Simerly C, Dominko T, Navara C, et al. Molecular correlates of primate nuclear transfer failures. Science. 2003;300(5617):297. PMID 12690191Animal — primate
  6. Hwang WS, Ryu YJ, Park JH, et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science. 2004;303(5664):1669-74. Retracted January 2006. PMID 14963337Retracted — the field's lesson
  7. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-76. PMID 16904174Established — animal/in vitro
  8. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861-72. PMID 18035408Established — human cells in vitro
  9. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-20. PMID 18029452Established — human cells in vitro
  10. Byrne JA, Pedersen DA, Clepper LL, et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature. 2007;450(7169):497-502. PMID 18004281Animal — primate
  11. Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells. Nature. 2010;467(7313):285-90. PMID 20644535In vitro — animal
  12. Polo JM, Liu S, Figueroa ME, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol. 2010;28(8):848-55. PMID 20644536In vitro — animal
  13. Tachibana M, Amato P, Sparman M, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228-38. PMID 23683578Human cells — in vitro
  14. Chung YG, Eum JH, Lee JE, et al. Human somatic cell nuclear transfer using adult cells. Cell Stem Cell. 2014;14(6):777-80. PMID 24746675Human cells — in vitro
  15. Yamada M, Johannesson B, Sagi I, et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature. 2014;510(7506):533-6. PMID 24776804Human cells — in vitro
  16. Mandai M, Watanabe A, Kurimoto Y, et al. Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med. 2017;376(11):1038-1046. PMID 28296613 · DOI 10.1056/NEJMoa1608368Human evidence — iPSC
  17. Liu Z, Cai Y, Wang Y, et al. Cloning of macaque monkeys by somatic cell nuclear transfer. Cell. 2018;172(4):881-887.e7. PMID 29395327Animal — primate
  18. Matoba S, Zhang Y. Somatic cell nuclear transfer reprogramming: mechanisms and applications. Cell Stem Cell. 2018;23(4):471-485. PMID 30033121Review
  19. Srirattana K, Kaneda M, Parnpai R. Strategies to improve the efficiency of somatic cell nuclear transfer. Int J Mol Sci. 2022;23(4):1969. PMID 35216087Review
  20. The Nobel Prize in Physiology or Medicine 2012: Sir John B. Gurdon and Shinya Yamanaka, "for the discovery that mature cells can be reprogrammed to become pluripotent." nobelprize.orgAward record
  21. World Health Assembly. Ethical, scientific and social implications of cloning in human health — resolutions of 1997 and 1998. World Health Organization, Geneva. WHO IRIS 10665/79553 · WHO IRIS 10665/79804Governance

Field status: no SCNT-derived cell therapy has regulatory approval anywhere as of September 2026. Concept and programme direction: Bogdan Dicoias, biochemist and inventor. Published by Panacea Bio Chem Scientific Communications. Sources on this page link PubMed, the Nobel Prize and WHO IRIS directly; identifiers re-verified 11 September 2026. Nothing here is medical advice.